Actinium Pharmaceuticals ... (ATNM)
AMEX: ATNM
· Real-Time Price · USD
1.69
0.04 (2.42%)
At close: Aug 15, 2025, 3:59 PM
1.69
0.00%
After-hours: Aug 15, 2025, 05:56 PM EDT
Actinium Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | 810K | n/a | n/a | n/a | 81K | n/a | n/a | n/a | 114K | 45K | 45K | 940K | 23K | 233K | 266K | 622K |
Cost of Revenue | 204K | 205K | n/a | 202K | 189K | 216K | 199K | 200K | 209K | n/a | 161K | 221K | 180K | 137K | 137K | n/a | n/a | n/a |
Gross Profit | -204K | -205K | 405K | -202K | -189K | -216K | -118K | -200K | -209K | n/a | -47K | -176K | -135K | 803K | -114K | 233K | 266K | 622K |
Operating Income | -7.5M | -16.64M | -7.5M | -12.6M | -12.42M | -9.6M | -10.34M | -14.35M | -15.64M | -11.58M | -11.29M | -9.8M | -7.85M | -5.16M | -8.05M | -6.47M | -5.08M | -5.37M |
Interest Income | 625K | 700K | 853K | 1.03M | 1.06M | 927K | 1.02M | 1.07M | 461K | 547K | 644K | 325K | 83K | 35K | 38K | 46K | 54K | 52K |
Pretax Income | -6.88M | -15.94M | -6.65M | -11.57M | -11.35M | -8.67M | -9.32M | -13.28M | -15.18M | -11.04M | -10.65M | -9.47M | -7.77M | -5.13M | -8.01M | -6.42M | -5.02M | -5.32M |
Net Income | -6.88M | -15.94M | -6.65M | -11.57M | -11.35M | -8.67M | -9.32M | -13.28M | -15.18M | -11.04M | -10M | -9.15M | -7.77M | -5.09M | -8.01M | -6.42M | -5.02M | -5.32M |
Selling & General & Admin | 2.62M | 8.94M | 2.69M | 2.83M | 3.59M | 2.96M | 2.31M | 2.73M | 4.56M | 3.73M | 3.96M | 3.07M | 3.23M | 1.74M | 2.65M | 1.99M | 1.71M | 1.72M |
Research & Development | 4.88M | 7.7M | 4.81M | 9.77M | 8.82M | 6.42M | 7.92M | 11.62M | 11.08M | 7.85M | 7.33M | 6.77M | 4.66M | 4.37M | 5.42M | 4.71M | 3.63M | 4.28M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 7.5M | 16.64M | 7.5M | 12.6M | 12.42M | 9.38M | 10.22M | 14.35M | 15.64M | 11.58M | 11.29M | 9.84M | 7.89M | 6.1M | 8.07M | 6.7M | 5.34M | 5.99M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 7.5M | 16.64M | 7.5M | 12.6M | 12.42M | 9.6M | 10.42M | 14.35M | 15.64M | 11.58M | 11.29M | 9.84M | 7.89M | 6.1M | 8.07M | 6.7M | 5.34M | 5.99M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 86.92K | n/a | -644K | -325K | n/a | -35K | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 31.2M | 31.2M | 31.2M | 31.07M | 30.1M | 27.89M | 27.63M | 27.06M | 26.22M | 25.7M | 25.68M | 24.93M | 23.73M | 22.14M | 21.54M | 21.54M | 20.23M | 18.38M |
Shares Outstanding (Diluted) | 31.2M | 31.2M | 31.2M | 31.07M | 30.1M | 27.89M | 27.63M | 27.06M | 26.22M | 25.7M | 25.68M | 25.16M | 23.73M | 22.14M | 21.54M | 21.54M | 20.23M | 18.38M |
EPS (Basic) | -0.22 | -0.51 | -0.21 | -0.37 | -0.38 | -0.31 | -0.34 | -0.49 | -0.58 | -0.43 | -0.39 | -0.37 | -0.33 | -0.23 | -0.37 | -0.3 | -0.25 | -0.29 |
EPS (Diluted) | -0.22 | -0.51 | -0.21 | -0.37 | -0.38 | -0.31 | -0.34 | -0.49 | -0.58 | -0.43 | -0.39 | -0.36 | -0.33 | -0.23 | -0.37 | -0.3 | -0.25 | -0.29 |
EBITDA | -7.5M | -16.64M | -7.3M | -12.4M | -12.23M | -9.38M | -10.14M | -14.15M | -15.43M | -11.4M | -11.13M | -9.58M | -7.67M | -5.03M | -7.91M | -6.34M | -4.95M | -5.25M |
EBIT | -6.88M | -15.94M | -7.5M | -12.6M | -12.42M | -9.6M | -10.34M | -14.35M | -15.64M | -11.58M | -11.29M | -9.8M | -7.85M | -5.16M | -8.05M | -6.47M | -5.08M | -5.37M |
Depreciation & Amortization | n/a | 205K | 204K | 202K | 189K | 216K | 199K | 200K | 209K | 182K | 161K | 221K | 180K | 137K | 137K | 133K | 129K | 125K |